Search
Search
[{{{type}}}] {{{reason}}}
{{/data.error.root_cause}}{{texts.summary}} {{#options.result.rssIcon}} RSS {{/options.result.rssIcon}}
{{/texts.summary}} {{#data.hits.hits}}{{{_source.title}}} {{#_source.showPrice}} {{{_source.displayPrice}}} {{/_source.showPrice}}
{{#_source.showLink}} {{/_source.showLink}} {{#_source.showDate}}{{{_source.displayDate}}}
{{/_source.showDate}}{{{_source.description}}}
{{#_source.additionalInfo}}{{#_source.additionalFields}} {{#title}} {{{label}}}: {{{title}}} {{/title}} {{/_source.additionalFields}}
{{/_source.additionalInfo}}Vertebrate Antibodies Limited
Vertebrate Antibodies Limited (VAL) was formed by research scientists from the University of Aberdeen with a wealth of experience in the development of high performance antibodies.
Vertebrate Antibodies Limited recently developed the EpitoGen COVID-19 ELISA tests, the only epitope-based ELISA tests and the only tests to utilize 5 viral COVID-19 antigens and include prevalent mutations. These tests are based on the new EpitoGen Technology that increases the sensitivity and specificity of COVID-19 tests.
